BRIEF published on 10/27/2025 at 10:14, 1 month 8 days ago Wüstenrot & Württembergische AG Launches €300 Million Subordinated Bond International Investors Capital Structure Wüstenrot & Württembergische AG €300 Million Subordinated Bond
PRESS RELEASE published on 10/27/2025 at 10:09, 1 month 8 days ago Wüstenrot & Württembergische AG issues subordinated bond worth €300 million Wüstenrot & Württembergische AG issues €300 million subordinated bond with a 20-year term and 4.983% coupon rate, optimizing capital structure. Market Conditions Coupon Rate Capital Structure Wüstenrot & Württembergische AG Subordinated Bond
BRIEF published on 08/14/2025 at 08:24, 3 months 21 days ago W&W Group Reports Strong First Half for 2025 Earnings Growth W&W Group Insurance Premiums Construction Financing First Half 2025
PRESS RELEASE published on 08/14/2025 at 08:19, 3 months 21 days ago W&W Group: Successful first half of 2025 W&W Group had a successful first half of 2025 with growth in earnings and new business, particularly in construction financing. Gross combined ratio in property insurance reached a record level of 83.8% Earnings 2025 W&W Group Construction Financing Property Insurance
BRIEF published on 03/28/2025 at 10:26, 8 months 7 days ago W&W-Group Appoints Matthias Bogk as New CFO Chief Financial Officer Appointment Financial Leadership Wüstenrot & Württembergische Matthias Bogk
PRESS RELEASE published on 03/28/2025 at 10:21, 8 months 7 days ago W&W-Group: Matthias Bogk new Chief Financial Officer Wüstenrot & Württembergische AG appoints Matthias Bogk as new Chief Financial Officer, effective from 1 July 2025, succeeding Alexander Mayer. Supervisory Board highlights Bogk's competence and values Mayer's contributions Chief Financial Officer Supervisory Board Wüstenrot & Württembergische AG Matthias Bogk Alexander Mayer
BRIEF published on 03/28/2025 at 08:19, 8 months 7 days ago W&W Group Reports Robust Start to 2025 Despite Past Challenges Financial Results Insurance Market Economic Challenges W&W Group 2025 Growth
PRESS RELEASE published on 03/28/2025 at 08:14, 8 months 7 days ago W&W Group with a strong start to 2025 W&W Group reports strong start to 2025 with significant growth in new business and consolidated earnings, despite challenges in 2024. Positive outlook for the year ahead Financial Year Outlook Consolidated Earnings W&W Group New Business
BRIEF published on 11/15/2024 at 10:14, 1 year ago W&W Group Reports Growth Amid Economic Challenges Economic Challenges Housing Market W&W Group Insurance Growth Natural Disasters
PRESS RELEASE published on 11/15/2024 at 10:09, 1 year ago W&W Group: Key portfolio figures expanded and on track operationally W&W Group expands key portfolio figures and stays on track operationally despite challenges. New lending business and insurance growth reported Operational Performance W&W Group Insurance Growth Lending Business Portfolio Figures
Published on 12/05/2025 at 02:35, 2 hours 50 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 25 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 20 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 25 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 55 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 34 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 10 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 15 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 25 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 40 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 41 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 24 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
